
|Articles|December 15, 2002
Three other glaucoma trials addressing IOP and visual field damage:
This study was designed to determine treatment sequences in patients whose advanced glaucoma was not able to be adequately controlled with maximum medical therapy.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants breakthrough therapy designation to Oculis’ privosegtor for optic neuritis
2
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
3
New optoretinography technique allows direct measurement of rod function in vivo
4
Long-lived Greenland sharks may point to new approaches for retinal disease
5












































